New Investing App Saves Investors an Average of $97,347

From Tradesmith | Ad

Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.

>>>

MRTX Insider Trading (Mirati Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.47%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,345,255.69

Mirati Therapeutics Insider Trading History Chart

Mirati Therapeutics Share Price & Price History

^$68.50

▼ -1.16 (-1.67%)

As of 06/28/2022 05:00 PM ET

Days: 30 | 90 | 365

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

Mirati Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/23/2022	Jamie Christensen	EVP	Sell	624	$63.54	$39,648.96	86,804
1/19/2022	Julie M. Cherrington	Director	Sell	1,475	$116.07	$171,203.25
1/18/2022	Charles M. Baum	Insider	Sell	2,517	$120.48	$303,248.16
1/18/2022	Jamie Christensen	EVP	Sell	627	$120.51	$75,559.77
1/18/2022	Vickie S. Reed	CAO	Sell	533	$120.48	$64,215.84
1/7/2022	Benjamin Hickey	EVP	Sell	1,964	$135.94	$266,986.16
1/7/2022	Vickie S. Reed	CAO	Sell	345	$135.94	$46,899.30
1/4/2022	Charles M. Baum	Insider	Sell	4,114	$147.75	$607,843.50
1/4/2022	Jamie Christensen	EVP	Sell	1,442	$147.72	$213,012.24
1/4/2022	Vickie S. Reed	CAO	Sell	758	$147.74	$111,986.92
12/6/2021	Jamie Christensen	EVP	Sell	1,201	$130.79	$157,078.79
12/3/2021	Charles M. Baum	Insider	Sell	47,204	$133.20	$6,287,572.80
6/18/2021	Charles M. Baum	CEO	Sell	40,000	$165.46	$6,618,400.00	152,714
5/24/2021	Jamie Christensen	EVP	Sell	435	$154.34	$67,137.90	53,850
4/5/2021	Bruce L. A. Carter	Director	Sell	2,250	$177.11	$398,497.50	5,725
3/19/2021	Benjamin Hickey	EVP	Sell	2,369	$176.44	$417,986.36	29,181
3/9/2021	Ltd. Braslyn	Major Shareholder	Sell	11,971	$197.67	$2,366,307.57
3/5/2021	Boxer Capital, Llc	Major Shareholder	Sell	400,005	$181.15	$72,460,905.75
2/2/2021	Bruce L. A. Carter	Director	Sell	2,250	$191.12	$430,020.00
2/2/2021	Daniel Faga	COO	Sell	1,340	$194.38	$260,469.20
1/29/2021	Maria E Martinez	Director	Sell	7,500	$203.54	$1,526,550.00	10,975
1/21/2021	Craig A. Johnson	Director	Sell	15,000	$211.55	$3,173,250.00	18,475
1/7/2021	Benjamin Hickey	EVP	Sell	2,078	$216.33	$449,533.74	21,858
1/7/2021	Daniel Faga	COO	Sell	2,625	$216.33	$567,866.25	26,228
1/6/2021	Charles M. Baum	CEO	Sell	4,511	$210.39	$949,069.29	91,933
1/6/2021	Vickie S. Reed	CAO	Sell	538	$210.39	$113,189.82	8,239
12/18/2020	Charles M. Baum	CEO	Sell	40,000	$234.48	$9,379,200.00	142,023
12/15/2020	Henry J Fuchs	Director	Sell	10,000	$233.39	$2,333,900.00
10/30/2020	Boxer Capital, Llc	Major Shareholder	Sell	400,000	$202.00	$80,800,000.00
10/28/2020	Ltd. Braslyn	Major Shareholder	Sell	295,436	$206.57	$61,028,214.52
8/10/2020	Henry J Fuchs	Director	Sell	10,000	$131.38	$1,313,800.00	12,000
6/12/2020	Ltd. Braslyn	Major Shareholder	Sell	600,000	$69.00	$41,400,000.00	2,535,966
5/11/2020	Isan Chen	EVP	Sell	33,334	$105.00	$3,500,070.00	72,735
4/20/2020	Craig A. Johnson	Director	Sell	15,000	$93.00	$1,395,000.00	17,000
4/17/2020	Charles M. Baum	CEO	Sell	40,000	$90.33	$3,613,200.00	146,466
1/10/2020	Boxer Capital, Llc	Major Shareholder	Buy	50,000	$97.50	$4,875,000.00
11/20/2019	Bruce L. A. Carter	Director	Sell	3,000	$94.74	$284,220.00	3,000
11/12/2019	Michael G Grey	Director	Sell	3,042	$102.44	$311,622.48	5,298
8/22/2019	Charles M. Baum	CEO	Sell	51,810	$86.22	$4,467,058.20	117,851
8/21/2019	Bruce L. A. Carter	Director	Sell	3,000	$89.24	$267,720.00	3,000
8/12/2019	Michael G Grey	Director	Sell	3,042	$92.27	$280,685.34	4,840
7/23/2019	Avoro Capital Advisors Llc	Major Shareholder	Sell	62,500	$101.88	$6,367,500.00
7/17/2019	Boxer Capital, Llc	Major Shareholder	Sell	725,008	$98.30	$71,268,286.40

Former Lawyer Went From $50K To $5.3M Trading Options

From Investing Daily | Ad

Slaving away for 70 hrs a week as a lawyer in Chicago, I was miserable.

I ran into guys who worked the trading floor at the local exchange. I began trading the same way they did. I started out with $50K (much more than I needed, actually).

I grew my $50K into $5.3M

I'll show you how I did it here.

SEC Filings (Institutional Ownership Changes) for Mirati Therapeutics (NASDAQ:MRTX)

Institutional Buying and Selling by Quarter

Mirati Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/27/2022	Walleye Capital LLC	2,691	$0.22M	0.0%	-87.2%	0.005%
5/23/2022	Neuberger Berman Group LLC	17,262	$1.42M	0.0%	-80.2%	0.031%
5/20/2022	International Biotechnology Trust PLC	188,500	$1.37M	0.3%	+49.0%	0.339%
5/20/2022	The Manufacturers Life Insurance Company	27,902	$2.32M	0.0%	N/A	0.050%
5/18/2022	BNP Paribas Arbitrage SA	27,147	$2.23M	0.0%	-34.2%	0.049%
5/18/2022	Nomura Holdings Inc.	22,039	$1.88M	0.0%	N/A	0.040%
5/17/2022	Walleye Capital LLC	2,691	$0.22M	0.0%	-87.2%	0.005%
5/17/2022	Weiss Multi Strategy Advisers LLC	15,927	$1.31M	0.0%	-20.5%	0.029%
5/17/2022	Advisors Asset Management Inc.	1,581	$0.13M	0.0%	-47.8%	0.003%
5/17/2022	Point72 Hong Kong Ltd	2,667	$0.22M	0.0%	N/A	0.005%
5/17/2022	Polar Capital Holdings Plc	29,390	$2.42M	0.0%	+10.2%	0.053%
5/17/2022	RA Capital Management L.P.	734,343	$60.38M	1.3%	+92.7%	1.322%
5/17/2022	Royal Bank of Canada	13,353	$1.10M	0.0%	-77.3%	0.024%
5/17/2022	Rock Springs Capital Management LP	559,734	$46.02M	1.2%	+36.4%	1.008%
5/17/2022	Dynamic Technology Lab Private Ltd	8,450	$0.70M	0.1%	N/A	0.015%
5/17/2022	Eaton Vance Management	30,637	$2.52M	0.0%	+200.8%	0.055%
5/17/2022	Eventide Asset Management LLC	453,781	$37.31M	0.6%	+55.6%	0.817%
5/17/2022	Ensign Peak Advisors Inc	92,617	$7.62M	0.0%	+0.8%	0.167%
5/17/2022	Guggenheim Capital LLC	27,800	$2.29M	0.0%	+14.3%	0.050%
5/16/2022	California State Teachers Retirement System	51,155	$4.21M	0.0%	-4.4%	0.092%
5/16/2022	Goldman Sachs Group Inc.	128,607	$10.57M	0.0%	-44.8%	0.232%
5/16/2022	Deerfield Management Company L.P. Series C	270,000	$22.20M	0.5%	+206.8%	0.486%
5/16/2022	Connacht Asset Management LP	3,318	$0.27M	0.1%	-48.6%	0.006%
5/16/2022	Glenview Capital Management LLC	116,110	$9.55M	0.2%	+153.5%	0.209%
5/16/2022	Captrust Financial Advisors	977	$80K	0.0%	+1,528.3%	0.002%
5/16/2022	Brinker Capital Investments LLC	7,188	$0.59M	0.0%	N/A	0.013%
5/16/2022	Woodline Partners LP	126,048	$10.36M	0.2%	+0.9%	0.227%
5/16/2022	Wellington Management Group LLP	2,482,521	$204.11M	0.0%	-21.1%	4.471%
5/16/2022	State Street Corp	1,423,565	$117.05M	0.0%	+37.5%	2.564%
5/16/2022	Paradigm Biocapital Advisors LP	98,383	$8.09M	2.1%	-62.2%	0.177%
5/16/2022	Echo Street Capital Management LLC	5,584	$0.46M	0.0%	N/A	0.010%
5/16/2022	Suvretta Capital Management LLC	510,331	$41.96M	1.3%	+26.7%	0.919%
5/16/2022	Engineers Gate Manager LP	25,822	$2.12M	0.1%	+414.8%	0.047%
5/16/2022	Ghost Tree Capital LLC	20,000	$1.64M	0.4%	-33.3%	0.036%
5/16/2022	Invesco Ltd.	426,989	$35.11M	0.0%	+7.4%	0.769%
5/16/2022	UBS Group AG	8,031	$0.66M	0.0%	-82.4%	0.014%
5/16/2022	Hsbc Holdings PLC	7,277	$0.61M	0.0%	N/A	0.013%
5/13/2022	Silverarc Capital Management LLC	46,122	$3.79M	1.6%	-24.1%	0.083%
5/13/2022	Rhenman & Partners Asset Management AB	149,800	$12.32M	1.2%	-0.1%	0.270%
5/13/2022	Renaissance Technologies LLC	94,000	$7.73M	0.0%	N/A	0.169%
5/13/2022	Bellevue Group AG	14,800	$1.22M	0.0%	-31.5%	0.027%
5/13/2022	Northern Trust Corp	200,214	$16.46M	0.0%	+0.9%	0.361%
5/13/2022	Charles Schwab Investment Management Inc.	392,958	$32.31M	0.0%	+2.8%	0.708%
5/13/2022	First Light Asset Management LLC	45,205	$3.72M	0.3%	-17.8%	0.081%
5/13/2022	First Trust Advisors LP	4,335	$0.36M	0.0%	-91.5%	0.008%
5/13/2022	Federated Hermes Inc.	259,207	$21.31M	0.0%	+0.1%	0.467%
5/13/2022	Parkman Healthcare Partners LLC	15,236	$1.25M	0.4%	+18.0%	0.027%
5/13/2022	Ergoteles LLC	4,440	$0.37M	0.0%	-70.1%	0.008%
5/13/2022	Candriam Luxembourg S.C.A.	506,773	$41.67M	0.3%	+2.9%	0.913%
5/13/2022	Vanguard Group Inc.	4,482,810	$368.58M	0.0%	+1.0%	8.073%
5/13/2022	Allianz Asset Management GmbH	15,115	$1.24M	0.0%	-35.5%	0.027%
5/13/2022	M28 Capital Management LP	82,900	$6.82M	6.3%	+331.8%	0.149%
5/13/2022	Lord Abbett & CO. LLC	308,285	$25.35M	0.1%	-38.0%	0.555%
5/13/2022	Dimensional Fund Advisors LP	189,529	$15.58M	0.0%	+122.2%	0.341%
5/12/2022	BlackRock Inc.	2,797,638	$230.02M	0.0%	+1.5%	5.038%
5/12/2022	Bollard Group LLC	15,600	$1.28M	0.0%	N/A	0.028%
5/12/2022	Rhumbline Advisers	35,534	$2.92M	0.0%	-7.6%	0.064%
5/12/2022	MetLife Investment Management LLC	2,397	$0.20M	0.0%	N/A	0.004%
5/12/2022	Artal Group S.A.	1,350,000	$111M	4.6%	-3.6%	2.431%
5/12/2022	Acadian Asset Management LLC	2,324	$0.19M	0.0%	N/A	0.004%
5/12/2022	FORA Capital LLC	4,570	$0.38M	0.1%	+65.5%	0.008%
5/12/2022	Capital Fund Management S.A.	50,315	$4.14M	0.0%	+100.8%	0.091%
5/12/2022	Bank of Montreal Can	199,882	$17.07M	0.0%	N/A	0.360%
5/12/2022	E Fund Management Co. Ltd.	3,321	$0.27M	0.0%	N/A	0.006%
5/12/2022	Eagle Asset Management Inc.	262,402	$21.57M	0.1%	+1.4%	0.473%
5/12/2022	AlphaCrest Capital Management LLC	7,416	$0.61M	0.0%	+37.2%	0.013%
5/12/2022	Citigroup Inc.	20,599	$1.69M	0.0%	-40.9%	0.037%
5/12/2022	Oppenheimer Asset Management Inc.	3,950	$0.33M	0.0%	N/A	0.007%
5/11/2022	US Bancorp DE	1,898	$0.16M	0.0%	+351.9%	0.003%
5/11/2022	Bank of New York Mellon Corp	158,279	$13.01M	0.0%	-5.9%	0.285%
5/11/2022	WINTON GROUP Ltd	6,477	$0.53M	0.0%	+316.5%	0.012%
5/10/2022	Sectoral Asset Management Inc.	59,837	$4.92M	0.9%	-21.1%	0.108%
5/10/2022	Profund Advisors LLC	6,190	$0.51M	0.0%	-9.2%	0.011%
5/10/2022	ProShare Advisors LLC	6,877	$0.57M	0.0%	-23.8%	0.012%
5/10/2022	TD Asset Management Inc.	47,235	$3.88M	0.0%	-25.1%	0.085%
5/10/2022	Lmcg Investments LLC	5,621	$0.46M	0.0%	N/A	0.010%
5/10/2022	B. Metzler seel. Sohn & Co. AG	5,302	$0.44M	0.0%	N/A	0.010%
5/10/2022	Fox Run Management L.L.C.	3,450	$0.28M	0.2%	N/A	0.006%
5/10/2022	Edmond DE Rothschild Holding S.A.	153,060	$12.59M	0.3%	+70.1%	0.276%
5/10/2022	Treasurer of the State of North Carolina	15,427	$1.27M	0.0%	+1.6%	0.028%
5/10/2022	Union Investments & Development Ltd.	1,800	$0.15M	0.1%	N/A	0.003%
5/9/2022	Fiera Capital Corp	280,717	$23.08M	0.1%	N/A	0.506%
5/9/2022	Campbell & CO Investment Adviser LLC	3,923	$0.32M	0.1%	N/A	0.007%
5/9/2022	Bank of Nova Scotia	110,000	$9.04M	0.0%	+90.0%	0.198%
5/9/2022	Principal Financial Group Inc.	10,088	$0.83M	0.0%	-3.4%	0.018%
5/9/2022	Swiss National Bank	91,300	$7.51M	0.0%	+14.8%	0.164%
5/9/2022	Bank Julius Baer & Co. Ltd Zurich	1,751	$0.14M	0.0%	N/A	0.003%
5/9/2022	Duality Advisers LP	23,506	$1.93M	0.2%	N/A	0.042%
5/9/2022	Teacher Retirement System of Texas	8,066	$0.66M	0.0%	+15.0%	0.015%
5/9/2022	Qube Research & Technologies Ltd	38,715	$3.18M	0.0%	N/A	0.070%
5/9/2022	Monaco Asset Management SAM	6,000	$0.49M	0.2%	N/A	0.011%
5/6/2022	WCM Investment Management LLC	30,639	$2.52M	0.0%	+15.8%	0.055%
5/6/2022	Sector Gamma AS	11,875	$0.98M	0.2%	-54.5%	0.021%
5/6/2022	State Board of Administration of Florida Retirement System	45,685	$3.76M	0.0%	-2.0%	0.082%
5/6/2022	IndexIQ Advisors LLC	515	$42K	0.0%	N/A	0.001%
5/5/2022	Aigen Investment Management LP	4,515	$0.37M	0.1%	+31.3%	0.008%
5/5/2022	New York State Common Retirement Fund	119,283	$9.81M	0.0%	+117.7%	0.215%
5/5/2022	Russell Investments Group Ltd.	58,254	$4.79M	0.0%	+20.3%	0.105%
5/4/2022	California Public Employees Retirement System	79,430	$6.53M	0.0%	-5.3%	0.143%
5/4/2022	Advisor Group Holdings Inc.	644	$52K	0.0%	+211.1%	0.001%

Data available starting January 2016

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase 3 clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Today's Range

Now: $68.50

$67.23

$70.44

50 Day Range

MA: $58.06

$39.16

$76.39

52 Week Range

Now: $68.50

$32.96

$195.99

Volume

890,015 shs

Average Volume

1,098,130 shs

Market Capitalization

$3.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64

Who are the company insiders with the largest holdings of Mirati Therapeutics?: Mirati Therapeutics' top insider shareholders include:
Charles M Baum (CEO)
Jamie Christensen (EVP)
Benjamin Hickey (EVP)
Daniel Faga (COO)
Craig A Johnson (Director)
Henry J Fuchs (Director)
Maria E Martinez (Director)
Vickie S Reed (CAO)
Bruce L A Carter (Director)
Boxer Capital, Llc (Major Shareholder)
Charles M Baum (Insider)
Julie M Cherrington (Director)
Ltd Braslyn (Major Shareholder)
Learn More about top insider investors at Mirati Therapeutics.
Who are the major institutional investors of Mirati Therapeutics?: Mirati Therapeutics' top institutional investors include:
Vanguard Group Inc. — 8.07%
BlackRock Inc. — 5.04%
Wellington Management Group LLP — 4.47%
State Street Corp — 2.56%
Artal Group S.A. — 2.43%
RA Capital Management L.P. — 1.32%
Learn More about top institutional investors of Mirati Therapeutics stock.
Which institutional investors are selling Mirati Therapeutics stock?: In the last quarter, MRTX stock was sold by these institutional investors:
Wellington Management Group LLP
Lord Abbett & CO. LLC
Paradigm Biocapital Advisors LP
Goldman Sachs Group Inc.
Neuberger Berman Group LLC
Artal Group S.A.
First Trust Advisors LP
Royal Bank of Canada
During the last year, company insiders that have sold Mirati Therapeutics company stock include:
Charles M Baum (CEO)
Jamie Christensen (EVP)
Benjamin Hickey (EVP)
Daniel Faga (COO)
Craig A Johnson (Director)
Learn More investors selling Mirati Therapeutics stock.
Which institutional investors are buying Mirati Therapeutics stock?: Within the previous quarter, MRTX stock was acquired by institutional investors including:
State Street Corp
RA Capital Management L.P.
Fiera Capital Corp
Bank of Montreal Can
Deerfield Management Company L.P. Series C
Eventide Asset Management LLC
Rock Springs Capital Management LP
Suvretta Capital Management LLC